These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28808501)

  • 1. Evolving treatment landscape for early and advanced pancreatic cancer.
    Lau SC; Cheung WY
    World J Gastrointest Oncol; 2017 Jul; 9(7):281-292. PubMed ID: 28808501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients.
    Kieler M; Unseld M; Bianconi D; Schindl M; Kornek GV; Scheithauer W; Prager GW
    J Clin Med; 2020 Feb; 9(3):. PubMed ID: 32121198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinoma.
    Hegewisch-Becker S; Aldaoud A; Wolf T; Krammer-Steiner B; Linde H; Scheiner-Sparna R; Hamm D; Jänicke M; Marschner N;
    Int J Cancer; 2019 Mar; 144(5):981-990. PubMed ID: 30006989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer.
    Kunzmann V; Herrmann K; Bluemel C; Kapp M; Hartlapp I; Steger U
    Case Rep Oncol; 2014 Sep; 7(3):648-55. PubMed ID: 25408659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness and resource utilization of
    Braiteh F; Patel MB; Parisi M; Ni Q; Park S; Faria C
    Cancer Manag Res; 2017; 9():141-148. PubMed ID: 28461766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancements in the management of pancreatic cancer: 2013.
    Saif MW
    JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for pancreatic cancer.
    Springfeld C; Jäger D; Büchler MW; Strobel O; Hackert T; Palmer DH; Neoptolemos JP
    Presse Med; 2019 Mar; 48(3 Pt 2):e159-e174. PubMed ID: 30879894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection of Locally Advanced Pancreatic Neoplasms after Neoadjuvant Chemotherapy with Nab-Paclitaxel and Gemcitabine following FOLFIRINOX Failure.
    Hahn S; Ayav A; Lopez A
    Case Rep Gastroenterol; 2017; 11(2):422-427. PubMed ID: 29033758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer.
    Kurimoto M; Kimura M; Usami E; Iwai M; Hirose T; Kawachi S; Yoshimura T
    Mol Clin Oncol; 2017 Jul; 7(1):125-130. PubMed ID: 28685089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: single institution retrospective review of efficacy and toxicity.
    Zhang Y; Hochster H; Stein S; Lacy J
    Exp Hematol Oncol; 2015; 4():29. PubMed ID: 26451276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant Chemotherapy after Surgery for Pancreatic Cancer].
    Furuse J
    Gan To Kagaku Ryoho; 2016 Feb; 43(2):160-4. PubMed ID: 27067680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.
    Shaib WL; Ip A; Cardona K; Alese OB; Maithel SK; Kooby D; Landry J; El-Rayes BF
    Oncologist; 2016 Feb; 21(2):178-87. PubMed ID: 26834159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOLFIRINOX
    Cho IR; Kang H; Jo JH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; An C; Park MS; Bang S
    World J Gastrointest Oncol; 2020 Feb; 12(2):182-194. PubMed ID: 32104549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA).
    Uccello M; Moschetta M; Mak G; Alam T; Henriquez CM; Arkenau HT
    Curr Oncol; 2018 Feb; 25(1):e90-e94. PubMed ID: 29507500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe.
    Javed MA; Beyer G; Le N; Vinci A; Wong H; Palmer D; Morgan RD; Lamarca A; Hubner RA; Valle JW; Alam S; Chowdhury S; Ma YT; Archibugi L; Capurso G; Maisonneuve P; Neesse A; Sund M; Schober M; Krug S
    Pancreatology; 2019 Jan; 19(1):97-104. PubMed ID: 30529068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer.
    Muranaka T; Kuwatani M; Komatsu Y; Sawada K; Nakatsumi H; Kawamoto Y; Yuki S; Kubota Y; Kubo K; Kawahata S; Kawakubo K; Kawakami H; Sakamoto N
    J Gastrointest Oncol; 2017 Jun; 8(3):566-571. PubMed ID: 28736643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in neoadjuvant chemotherapy could alter the prognosis of patients with pancreatic adenocarcinoma: A case report.
    Meyer A; Carvalho BJ; Medeiros KA; Pipek LZ; Nascimento FS; Suzuki MO; Munhoz JV; Iuamoto LR; Carneiro-D'Alburquerque LA; Andraus W
    World J Clin Cases; 2021 May; 9(14):3418-3423. PubMed ID: 34002153
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kim G
    Cancer Manag Res; 2017; 9():85-96. PubMed ID: 28356771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive factors in pancreatic cancer.
    Dell'Aquila E; Fulgenzi CAM; Minelli A; Citarella F; Stellato M; Pantano F; Russano M; Cursano MC; Napolitano A; Zeppola T; Vincenzi B; Tonini G; Santini D
    Oncotarget; 2020 Mar; 11(10):924-941. PubMed ID: 32206189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis.
    Pusceddu S; Ghidini M; Torchio M; Corti F; Tomasello G; Niger M; Prinzi N; Nichetti F; Coinu A; Di Bartolomeo M; Cabiddu M; Passalacqua R; de Braud F; Petrelli F
    Cancers (Basel); 2019 Apr; 11(4):. PubMed ID: 30959763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.